Oventus Medical logo

OVN - Oventus Medical Share Price

A$0.68 -0.0  -2.9%

Last Trade - 6:10am

Sector
Healthcare
Size
Micro Cap
Market Cap £40.3m
Enterprise Value £38.7m
Revenue £257k
Position in Universe 746th / 1837
Bullish
Bearish
Unlock OVN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OVN Revenue Unlock OVN Revenue

Net Income

OVN Net Income Unlock OVN Revenue

Normalised EPS

OVN Normalised EPS Unlock OVN Revenue

PE Ratio Range

OVN PE Ratio Range Unlock OVN Revenue

Dividend Yield Range

OVN Dividend Yield Range Unlock OVN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OVN EPS Forecasts Unlock OVN Revenue
Profile Summary

Oventus Medical Limited is an Australia-based medical device company that is commercializing a suite of oral appliances for the treatment of sleep apnea and snoring. The principal activities of the Company consist of the commercialization and distribution of the O2Vent Mono in Australia, as well as development of a pipeline or products to treat segments of the snoring and sleep and apnea market. These segments include those that do not comply or adhere to existing treatment options due to nasal obstruction and/or inability to utilize the continuous positive airway pressure (CPAP) mask. Its devices have an airway within the device that delivers air to the back of the mouth bypassing multiple obstructions from the nose, soft palate and tongue. The O2Vent is designed to allow nasal breathing when the nose is unobstructed. It uses three-dimensional (3D) metal printing technologies to manufacture medical devices for the treatment of sleep apnea.

Directors
Last Annual June 30th, 2019
Last Interim June 30th, 2019
Incorporated September 23, 2015
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 112,024,047
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OVN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OVN
Upcoming Events for OVN
Friday 15th November, 2019 Estimate
Oventus Medical Ltd Annual Shareholders Meeting
Similar to OVN
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.